Journal of Clinical Oncology

Reply to H.O. Al-Shamsi et al

B Brooke E. Wilson (Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada) K Kristin Wright (Brooke E. Wilson, MBBS, MSc, BSc, FRACP Department of Oncology, Queen's University, Kingston, ON, Canada, Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada and School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia, Kristin Wright, MD Department of Oncology, Queen's University, Kingston, ON, Canada and Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada and...) C Christopher M. Booth (Department of Oncology, Queen’s University, Kingston, ON, Canada)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 1
Published January 01, 2025
Pages 111-112
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

B

Brooke E. Wilson

Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada

K

Kristin Wright

Brooke E. Wilson, MBBS, MSc, BSc, FRACP Department of Oncology, Queen's University, Kingston, ON, Canada, Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada and School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia, Kristin Wright, MD Department of Oncology, Queen's University, Kingston, ON, Canada and Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada and...

C

Christopher M. Booth

Department of Oncology, Queen’s University, Kingston, ON, Canada

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001